COVID-19 Vaccines Concept

subject area of

• (Mis)Communication of COVID‐19 vaccine benefits and harms  Journal Articles
• 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19  Journal Articles
• SARS‐CoV‐2 seroprevalence among blood donors in Uganda: 2019–2022  Journal Articles
• A Qualitative Analysis of the Functions of Primary Care Nurses in COVID-19 Vaccination.  Journal Articles
• A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera  Journal Articles
• A cross-sectional analysis of the association between social capital and willingness to get COVID-19 vaccine in Ontario, Canada  Journal Articles
• A fast, efficient, and scalable method for purifying recombinant SARS-CoV-2 spike protein  Journal Articles
• A multimethods randomized trial found that plain language versions improved adults understanding of health recommendations  Journal Articles
• A next-generation inhalable dry powder COVID vaccine  Journal Articles
• A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial  Journal Articles
• A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial  Journal Articles
• A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®  Journal Articles
• AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update  Journal Articles
• Acceptance and attitudes towards COVID-19 vaccination during pregnancy in Canada.  Journal Articles
• Acceptance of COVID-19 Vaccination Among Health System Personnel  Journal Articles
• Accuracy of Self-Reported COVID-19 Vaccination Status Compared With a Public Health Vaccination Registry in Québec: Observational Diagnostic Study  Journal Articles
• Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19  Journal Articles
• Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia  Journal Articles
• Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia  Journal Articles
• Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study  Journal Articles
• Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia  Journal Articles
• Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein  Journal Articles
• Applied behavioral economics and public health policies: Historical precedence and translational promise  Journal Articles
• Attitudes, Beliefs, and Intention to Receive a COVID-19 Vaccine for Pediatric Patients With Sickle Cell Disease.  Journal Articles
• BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan  Journal Articles
• BNT162b2 mRNA COVID-19 against symptomatic Omicron infection following a mass vaccination campaign in southern Brazil: A prospective test-negative design study  Journal Articles
• Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study  Journal Articles
• Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey  Journal Articles
• Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection  Journal Articles
• Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1  Journal Articles
• COVID-19 Vaccination Prioritization on the Basis of Cardiovascular Risk Factors and Number Needed to Vaccinate to Prevent Death  Journal Articles
• COVID-19 Vaccine Perceptions and Differences by Sex, Age, and Education in 1,367 Community Adults in Ontario  Journal Articles
• COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects  Journal Articles
• COVID-19 boosters in rich nations will delay vaccines for all  Journal Articles
• COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies  Journal Articles
• COVID-19 vaccine reactogenicity among participants enrolled in the GENCOV study  Journal Articles
• COVID-19 vaccines and kidney disease  Journal Articles
• COVID-19 vaccines for Palestinians  Journal Articles
• COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development  Journal Articles
• Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic Diseases  Journal Articles
• Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccines.  Journal Articles
• Cerebral Venous Sinus Thrombosis and Papilledema in Vaccine-Induced Thrombotic Thrombocytopenia After SARS-CoV-2 Vaccination  Journal Articles
• Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study.  Journal Articles
• Chronic Immune Activation and CD4+ T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy  Journal Articles
• Clinical Practice Recommendations on the Effect of COVID-19 Vaccination Strategies on Outcomes in Solid Organ Transplant Recipients.  Journal Articles
• Commentary on Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection  Journal Articles
• Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study  Journal Articles
• Coronavirus Disease 2019 Vaccination Is Associated With Reduced Outpatient Antibiotic Prescribing in Older Adults With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2: A Population-Wide Cohort Study  Journal Articles
• Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV  Journal Articles
• Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination  Journal Articles
• Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.  Journal Articles
• Demographic characteristics, outcomes and experience of patients using virtual urgent care services from 14 emergency department led sites in Ontario  Journal Articles
• Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV  Journal Articles
• Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients  Journal Articles
• Diagnostic accuracy of Augurix COVID‐19 IgG serology rapid test  Journal Articles
• Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID‐19 vaccines: A systematic review and meta‐analysis  Journal Articles
• Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia  Journal Articles
• Early Treatment with Pegylated Interferon Lambda for Covid-19  Journal Articles
• Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey  Journal Articles
• Effectiveness and Duration of Protection of a Fourth Dose of Coronavirus Disease 2019 Messenger RNA Vaccine Among Long-term Care Residents in Ontario, Canada  Journal Articles
• Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies  Journal Articles
• Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study  Journal Articles
• Efficacy and safety of COVID-19 vaccination in solid organ transplant recipients: A systematic review and network meta-analysis  Journal Articles
• Efficient capture of recombinant SARS-CoV-2 receptor-binding domain (RBD) with citrate-coated magnetic iron oxide nanoparticles  Journal Articles
• Emergency use authorisation for COVID-19 vaccines: lessons from Ebola  Journal Articles
• Ending COVID-19: progress and gaps in research—highlights of the July 2020 GloPID-R COVID-19 Research Synergies Meetings  Journal Articles
• Epidemiology of VITT  Journal Articles
• Epidemiology of VITT.  Journal Articles
• Erythro-VLPs: Anchoring SARS-CoV-2 spike proteins in erythrocyte liposomes  Journal Articles
• Estimated Effectiveness of Postpartum Maternal Messenger RNA COVID-19 Vaccination Against Delta and Omicron SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months  Journal Articles
• Evaluating COVID-19 vaccines in the real world  Journal Articles
• Evaluating methods for risk prediction of Covid-19 mortality in nursing home residents before and after vaccine availability: a retrospective cohort study  Journal Articles
• Evolutionary trajectory of SARS-CoV-2 and emerging variants  Journal Articles
• Exclusion of pregnant and lactating women from COVID-19 vaccine trials: a missed opportunity  Journal Articles
• Exploring Barriers and Facilitators to COVID-19 Vaccination in People Planning Pregnancy, Trying to Conceive, Pregnant, and Postpartum: A Mixed-Methods Study  Journal Articles
• Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19  Journal Articles
• Factors Associated With Willingness to Receive a COVID-19 Vaccine Among 23,819 Adults Aged 50 Years or Older: An Analysis of the Canadian Longitudinal Study on Aging  Journal Articles
• Factors associated with COVID-19 vaccination in young children  Journal Articles
• Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2  Journal Articles
• Global inequity creates local insufficiency: A qualitative study of COVID-19 vaccine implementation challenges in low-and-middle-income countries  Journal Articles
• Guidelines for the prevention and management of children and adolescents with COVID-19  Journal Articles
• Healthy vaccinee effect: a bias not to be forgotten in observational studies on COVID-19 vaccine effectiveness. Authors's reply  Journal Articles
• Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P’s) for anti-PF4 diseases  Journal Articles
• High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination  Journal Articles
• How do perceptions of Covid-19 risk impact pregnancy-related health decisions? A convergent parallel mixed-methods study protocol  Journal Articles
• Immunological considerations for COVID-19 vaccine strategies  Journal Articles
• Immunomodulatory drugs have divergent effects on humoral and cellular immune responses to SARS-CoV-2 vaccination in people living with rheumatoid arthritis  Journal Articles
• Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease  Journal Articles
• In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant)  Journal Articles
• In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose  Journal Articles
• In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose  Journal Articles
• Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal study on Aging (CLSA)  Journal Articles
• Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022  Journal Articles
• Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.  Journal Articles
• Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group  Journal Articles
• Kukaa Salama (Staying Safe): a pre-post trial of an interactive informational mobile health intervention for increasing COVID-19 prevention practices with urban refugee youth in Uganda  Journal Articles
• Kukaa Salama (Staying Safe): study protocol for a pre/post-trial of an interactive mHealth intervention for increasing COVID-19 prevention practices with urban refugee youth in Kampala, Uganda  Journal Articles
• Lessons from vaccine-induced immune thrombotic thrombocytopenia  Journal Articles
• Lien possible entre rhabdomyolyse et vaccin anti-SRAS-CoV-2 à ARNm chez une patiente porteuse d’une mutation du gène RYR1  Journal Articles
• Management of anaphylaxis due to COVID‐19 vaccines in the elderly  Journal Articles
• Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study  Journal Articles
• Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses  Journal Articles
• Myelin Oligodendrocyte Glycoprotein Antibody-Mediated Optic Neuritis Following COVID-19 Vaccination.  Journal Articles
• Natural immunity helps overcome the age-related decline of SARS-CoV-2 vaccine immunogenicity  Journal Articles
• Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy  Journal Articles
• No apparent association between mRNA COVID-19 vaccination and venous thromboembolism  Journal Articles
• Omission of alcohol skin cleansing and risk of adverse events in long-term care residents undergoing COVID-19 vaccination: A cohort study  Journal Articles
• POS1208 EQUITY CONSIDERATIONS IN COVID-19 VACCINATION STUDIES OF INDIVIDUALS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES  Conferences
• Pathogenesis, immunology, and immune‐targeted management of the multisystem inflammatory syndrome in children (MIS‐C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper  Journal Articles
• Perceptions of COVID-19 risk, vaccine access and confidence: a qualitative description of South Asians in Canada  Journal Articles
• Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response  Journal Articles
• Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group  Journal Articles
• Plain Language vs Standard Format for Youth Understanding of COVID-19 Recommendations  Journal Articles
• Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B  Journal Articles
• Priority setting during the COVID-19 pandemic: going beyond vaccines  Journal Articles
• Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey  Journal Articles
• Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness  Journal Articles
• R&D during public health emergencies: the value(s) of trust, governance and collaboration  Journal Articles
• Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study  Journal Articles
• Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories  Journal Articles
• Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis.  Journal Articles
• Recent Vaccination Against SARS-CoV-2 Is Associated with Less Severe Disease in Working-Age Adults.  Journal Articles
• Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia  Journal Articles
• Recommendations for the clinical and laboratory diagnosis of VITT against COVID‐19: Communication from the ISTH SSC Subcommittee on Platelet Immunology  Journal Articles
• Reply to Letter to the Editor: Exploring Barriers and Facilitators to COVID-19 Vaccination in People Planning Pregnancy, Trying to Conceive, Pregnant, and Postpartum.  Journal Articles
• Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”  Journal Articles
• Reporting of health equity considerations in vaccine trials for COVID-19: a methodological review  Journal Articles
• Reporting of health equity considerations in vaccine trials for COVID-19: author’s reply  Journal Articles
• Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2  Journal Articles
• Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study  Journal Articles
• Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study  Journal Articles
• Risk of SARS-CoV-2 infection following initial COVID-19 vaccination: Population-based cohort study  Journal Articles
• Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines  Journal Articles
• SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia  Journal Articles
• SARS-CoV-2 testing, test positivity and vaccination in social housing residents compared with the general population: a retrospective population-based cohort study.  Journal Articles
• SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection  Journal Articles
• SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study  Journal Articles
• SARS-CoV-2, Tdap, and influenza vaccination during pregnancy from 2019 to 2022 in Ontario, Canada: a population-based retrospective cohort study.  Journal Articles
• Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, Ontario.  Journal Articles
• Social Media Misinformation about Pregnancy and COVID-19 Vaccines: A Systematic Review  Journal Articles
• Sociodemographic factors associated with vaccine hesitancy in the South Asian community in Canada  Journal Articles
• South Asian Youth as Vaccine Agents of Change (SAY-VAC): evaluation of a public health programme to mobilise and empower South Asian youth to foster COVID-19 vaccine-related evidence-based dialogue in the Greater Toronto and Hamilton Area, Canada  Journal Articles
• Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study  Journal Articles
• Supporting the pandemic response and timely access to COVID-19 vaccines: a case for stronger priority setting and health system governance in Nigeria  Journal Articles
• The COVID‐19 pandemic and its consequences for chronic pain: a narrative review  Journal Articles
• The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021  Journal Articles
• The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020  Journal Articles
• The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021  Journal Articles
• The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021  Journal Articles
• The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020  Journal Articles
• The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021  Journal Articles
• The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose  Journal Articles
• The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper  Journal Articles
• The COVID-19 Vaccine: Why Should I Get the Vaccines and the Boosters?  Journal Articles
• The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis  Journal Articles
• The Omicron Paradox: Is It Omicron or Is It What Happened During the Omicron Period?  Journal Articles
• The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach  Journal Articles
• The Role of a Resilient Information Infrastructure in COVID-19 Vaccine Uptake in Ontario  Journal Articles
• The association between frailty, long-term care home characteristics and COVID-19 mortality before and after SARS-CoV-2 vaccination: a retrospective cohort study  Journal Articles
• The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia  Journal Articles
• The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials  Journal Articles
• The impact of Gam-COVID-Vac, an Adv5/Adv26 COVID-19 vaccine, on the biomarkers of endothelial function, coagulation and platelet activation  Journal Articles
• The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake  Journal Articles
• The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic  Journal Articles
• Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords  Journal Articles
• Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination  Journal Articles
• Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum  Journal Articles
• Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial  Journal Articles
• Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination  Journal Articles
• Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination  Journal Articles
• Transmission dynamics are crucial to COVID-19 vaccination policy  Journal Articles
• Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)  Journal Articles
• Uncertainty in COVID-19 transmission could undermine our ability to predict long COVID.  Journal Articles
• Unilateral Axillary Lymphadenopathy After COVID-19 Vaccine Causing Medial Cord Plexopathy  Journal Articles
• Unnecessary hesitancy on human vaccine tests—Response  Journal Articles
• Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach  Journal Articles
• Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021  Journal Articles
• Use of complementary medicine and its association with SARS-CoV-2 vaccination during the COVID-19 pandemic: a longitudinal cohort study  Journal Articles
• Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders  Journal Articles
• Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada  Journal Articles
• Vaccine-induced immune thrombotic thrombocytopenia  Journal Articles
• Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil  Journal Articles
• Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials  Journal Articles
• Vaccines to prevent COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING VACCINE Project)  Journal Articles
• Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources  Journal Articles
• Variant Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: Case Report and Review of the Literature.  Journal Articles
• WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations  Journal Articles
• What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 2)  Journal Articles
• What is the role of primary care in the COVID-19 vaccine roll-out and the barriers and facilitators to an equitable vaccine roll-out? A rapid scoping review of nine jurisdictions  Journal Articles
• When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study  Journal Articles
• “I shall not poison my child with your human experiment”: Investigating predictors of parents’ hesitancy about vaccinating younger children (<12) in Canada  Journal Articles